2014 Annual Meeting | 8HC.006 - Critical Care EEG Monitoring

Date Saturday 05/03/14

Time 08:00 AM - 12:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Aatif M. Husain, MD

Topic(s) Neuro Trauma, Critical Care, and Sports Neurology

Learning Objectives Participants should be able to recognize appropriate patients who may benefit from cEEG monitoring; appreciate the nuanced interpretation of cEEG data and differentiate artifacts from cerebral activity; recognize the value and limitations of quantitative analysis of cEEG and apply this to their practice settings; understand the difference between recurrent electrographic seizures and status epilepticus and select appropriately aggressive therapy, thereby improving patient outcomes; and appreciate the economic and medicolegal impact of providing cEEG monitoring to critically ill patients.

CME Available No CME available

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic

Event Timeline
08:00 AM - 08:05 AM		Introduction Aatif M. Husain, MD
08:05 AM - 08:45 AM		Rationale for CEEG Monitoring Imran I. Ali, MD, FAAN
08:45 AM - 09:25 AM		CEEG Interpretation Suzette M. LaRoche, MD, FAAN
09:25 AM - 10:05 AM		Quantitative EEG Analysis Cecil D. Hahn, MD
10:05 AM - 10:20 AM		Break
10:20 AM - 11:00 AM		Treatment of ICU Seizures and Status Epilepticus Aatif M. Husain, MD
11:00 AM - 11:40 AM		Developing a CEEG Monitoring Program Saurabh R. Sinha, MD, PhD, FAAN
11:40 AM - 12:00 PM		Questions and Answers

Faculty Disclosures
Aatif M. Husain, MD	Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Husain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlackThorn Pharmaceuticals. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuiticals. Dr. Husain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Husain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis Pharmaceuitcals. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Pharmaceuticals. Dr. Husain has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Husain has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Husain has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for International Federation of Clinical Neurophysiology. Dr. Husain has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Clinical Neurophysiology Society. Dr. Husain has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Husain has received research support from Marinus Pharmaecuticals. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has a non-compensated relationship as a Vice Chair of CNP MOC committee with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Suzette M. LaRoche, MD, FAAN	Dr. LaRoche has received intellectual property interests from a discovery or technology relating to health care. Dr. LaRoche has received publishing royalties from a publication relating to health care. Dr. LaRoche has a non-compensated relationship as a President with American Clinical Neurophysiology Society that is relevant to AAN interests or activities.
Imran I. Ali, MD, FAAN	Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Cecil D. Hahn, MD	Dr. Hahn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Holberg EEG. Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Hahn has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various legal firms. Dr. Hahn has received publishing royalties from a publication relating to health care. Dr. Hahn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with CADTH.
Saurabh R. Sinha, MD, PhD, FAAN	Dr. Sinha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical. Dr. Sinha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova, Inc.. Dr. Sinha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharmaceuticals. Dr. Sinha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Sciences. Dr. Sinha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acquestive. Dr. Sinha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basilea Inc. Dr. Sinha has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlackThorn Therapeutics. Dr. Sinha has received stock or an ownership interest from Pfizer Inc.. The institution of Dr. Sinha has received research support from Monteris Medical. The institution of Dr. Sinha has received research support from Eisai Inc.. The institution of Dr. Sinha has received research support from Sage Therapeutics. Dr. Sinha has received publishing royalties from a publication relating to health care. Dr. Sinha has a non-compensated relationship as a Board Member/Officer with American Clinical Neurophysiology Soceity that is relevant to AAN interests or activities. Dr. Sinha has a non-compensated relationship as a Board Member/Officer with ABRET Lab-LTM Board that is relevant to AAN interests or activities. Dr. Sinha has a non-compensated relationship as a Board Member with American Board of Clinical Neurophysiology that is relevant to AAN interests or activities. Dr. Sinha has a non-compensated relationship as a Committee Member with American Epilepsy Society that is relevant to AAN interests or activities.